Ona Therapeutics raised $86.6M in a Series B round announced on June 4, 2026. Ona Therapeutics is focused on the discovery and development of therapeutic biologics to treat metastatic cancer.
Ona Therapeutics is focused on the discovery and development of therapeutic biologics to treat metastatic cancer.
Ona Therapeutics, based in Barcelona, Spain, announced $86.6M in Series B financing on June 4, 2026.
Participants include Korys, Cofides, CDTI, FundPlus NV, Columbus Venture Partners, Alta Life Sciences, Ysios Capital, Asabys Partners, Mérieux Equity Partners, Bpifrance.
CeQur is a medical device company that develops and manufactures wearable, injection-free insulin delivery solutions for people with diabetes.
Semble provides practice management software, workflows and integrations for private medical practices.